Hydration Pharmaceuticals Company Limited · ASX:HPC
Hydration Pharmaceuticals — The Hydration Pharmaceuticals Company — Shareholder Meeting (May 2026)
9 slides from Hydration Pharmaceuticals's shareholder meeting presentation, May 29, 2026
Slide 1: AGM 29 May 2026
For personal use only ASX: HPC AGM 29 May 2026 1
Slide 2: HydraLyte: A Global Hydralyte Powerhouse
2 HydraLyte: A Global Hydralyte Powerhouse For personal use only USA now sole focus of listed company Canada + ROW (sold Oct 24) ~US$9.5m USA Australia (sold 2014) Now single market focus ~$80m Revenue of US$2.4m ~$2 billion category 2025 Company estimate using 52 week Circana POS + estimates for Am
Slide 3: US products have evolved to meet consumer, category and E-comm economics
US products have evolved to meet consumer, category and E-comm economics HydraLyte at the intersection of daily rehydration and drinkable vitamins - leading industry innovation For personal use only Original Products from AUS / CA US growth drivers NEW TO MARKET HydraLyte Plus Liver H2 2024: Signifi
Slide 4: Why Hydralyte PLUS?
Why Hydralyte PLUS? For personal use only Hydralyte PLUS combines rapid rehydration with clinically proven supplement mixes, tailored to your health goals to Transform your morning ritual Supplements Hydration (Competitive/ Saturated) White Space supplements electrolytes ~$2BI Category 2in1 morning
Slide 5: #1 SKU: Liver Support
#1 SKU 3x Sales Growth Over 3 Years Liver Support $160,000 Monthly Amazon $140,000 sales since Jan of 2023 For personal use only In market: $35k a week on Amazon +40% YTD Growth $120,000 $100,000 Electrolytes + Detox $80,000 $60,000 18 Ingredients $40,000 $20,000 $- Inc. Milk Thistle 1 3 5 7 9 11 13
Slide 6: NEW Metabolic Support
NEW Metabolic Support Category Trends and Science Consumers are becoming more aware of the importance of For personal use only gut health and focusing on probiotics. Clinically studied New! Akkermansia has proven weight management benefits Our 5-strain blend features 20B CFU in every serving. Probio
Slide 7: Hydration + Metabolic already gaining traction with higher repeat rate
Hydration + Metabolic already gaining traction with higher repeat rate and shorter repeat period than best seller For personal use only Hydralyte Metabolic Supprt Daily Sales (USD) $1,200 $1,000 Highest rated product in Hydralyte USA $800 history $600 $400 $200 $- 1 9 17 25 33 41 49 57 65 73 81 89 9
Slide 8: New customers demand caused 2025 shortages on steady state SKU
New customers demand caused supply 2025 shortages on steady state SKU. Now back in stock with supply secure For personal use only Gross sales per month (USD), trailing 12 months $50,000 $45,000 Extreme sales spike $40,000 depleted available inventory into back half of $35,000 2025 $30,000 $25,000 No
Slide 9: Cash required to operate continues to fall
For personal use only Cash required to operate continues to fall Sales grew 11% quarter on quarter Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 despite inventory constraints at 2023 2023 2023 2023 2024 2024 2024 2024 2025 2025 2025 2025 2026 beginning of year. In February company made further (587) reduct
The Hydration Pharmaceuticals Company — Shareholder Meeting (May 2026) on 6ix